Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Egberg

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Thrombosis Research|March 1, 1982
Antithrombin assay - the use of human or bovine thrombin and the observation of a "second" heparin cofactorP Friberger, N Egberg, E Holmer, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2005
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination--a rebuttalN Egberg, I Fagerberg, A Hillarp, et al.
Human Molecular Genetics|April 1, 1992
Identification of a new nonsense mutation in the von Willebrand factor gene in patients with von Willebrand disease type IIIZ P Zhang, G Falk, M Blombäck, et al.
Thrombosis Research|October 1, 1991
A new assay for beta-thromboglobulin in urineP Hjemdahl, C Perneby, E Theodorsson, et al.
Clinical Science (London, England : 1979)|April 1, 1989
Altered platelet function during mental stress and adrenaline infusion in humans: evidence for an increased aggregability in vivo as measured by filtragometryP T Larsson, P Hjemdahl, G Olsson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1993
Comparison of three independent methods as estimates of platelet inhibition after a single dose of acetylsalicylic acidK E Karlberg, J Chen, N Egberg, et al.
Human Molecular Genetics|December 1, 1992
A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish vWD type III patientsZ P Zhang, G Falk, M Blombäck, et al.
Journal of Cardiovascular Risk|June 1, 1997
Nicotinic acid treatment shifts the fibrinolytic balance favourably and decreases plasma fibrinogen in hypertriglyceridaemic menJ O Johansson, N Egberg, A Asplund-Carlson, et al.
Genomics|May 1, 1994
Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish originZ P Zhang, M Blombäck, N Egberg, et al.
Platelets|November 4, 2010
Original article: evaluation of platelet function by flow cytometric measurement of ligand bindingA Bunescu, J Lundahl, T Söderström, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Thrombosis Research|March 1, 1982
Antithrombin assay - the use of human or bovine thrombin and the observation of a "second" heparin cofactorP Friberger, N Egberg, E Holmer, et al.
Journal of Thrombosis and Haemostasis : JTH|October 1, 2005
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination--a rebuttalN Egberg, I Fagerberg, A Hillarp, et al.
Human Molecular Genetics|April 1, 1992
Identification of a new nonsense mutation in the von Willebrand factor gene in patients with von Willebrand disease type IIIZ P Zhang, G Falk, M Blombäck, et al.
Thrombosis Research|October 1, 1991
A new assay for beta-thromboglobulin in urineP Hjemdahl, C Perneby, E Theodorsson, et al.
Clinical Science (London, England : 1979)|April 1, 1989
Altered platelet function during mental stress and adrenaline infusion in humans: evidence for an increased aggregability in vivo as measured by filtragometryP T Larsson, P Hjemdahl, G Olsson, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|December 1, 1993
Comparison of three independent methods as estimates of platelet inhibition after a single dose of acetylsalicylic acidK E Karlberg, J Chen, N Egberg, et al.
Human Molecular Genetics|December 1, 1992
A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish vWD type III patientsZ P Zhang, G Falk, M Blombäck, et al.
Journal of Cardiovascular Risk|June 1, 1997
Nicotinic acid treatment shifts the fibrinolytic balance favourably and decreases plasma fibrinogen in hypertriglyceridaemic menJ O Johansson, N Egberg, A Asplund-Carlson, et al.
Genomics|May 1, 1994
Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish originZ P Zhang, M Blombäck, N Egberg, et al.
Platelets|November 4, 2010
Original article: evaluation of platelet function by flow cytometric measurement of ligand bindingA Bunescu, J Lundahl, T Söderström, et al.
Pageof 11